Private Insurance for Cancer: What Oncology Care It Covers

A cancer diagnosis raises urgent questions about treatment — and about cost. In Israel much of cancer care is funded through the public health basket, but private health insurance policies are designed to fill the gaps: drugs not yet in the basket, private diagnostic tests, freedom of choice, speed, and a second opinion. This guide explains in plain language what a private policy typically covers in oncology, while stressing that the exact terms always depend on your specific policy.

The public health basket vs. your private policy

The starting point in Israel is that the national health basket already funds a large share of oncology care — surgery, radiation, chemotherapy, and many drugs that have been added to the basket. Private insurance does not replace the basket; it fills the gaps: drugs not yet in the basket, private diagnostic tests, choice of doctor and facility, shorter waiting times, and a second opinion.

When a drug is in the basket but not approved for your exact indication, there is sometimes an additional public route through your HMO's exceptions committee. Understanding both worlds helps you know when the private policy comes into play and when the public route is the right address.

Oncology drugs outside the basket

The most significant component of private oncology cover is usually the out-of-basket drugs rider. Oncology and hemato-oncology drugs approved in a recognized country are one of the most common categories included in such cover, and the ceilings are high — typically renewing once every two years.

• Commonly cited ceilings range up to about ₪1,000,000 for personalized drugs, and some "special drugs outside the basket" plans reach up to about ₪3,000,000 — as typical figures, not a guarantee.
• Eligibility usually rests on cumulative conditions: that the drug is oncological or hemato-oncological, and that it is registered or approved in a recognized country for the relevant indication.
• The definition of a "recognized country" and of a suitable indication varies between policies — this is exactly where reading your own wording matters.

Personalized drugs and targeted therapies

Modern oncology relies increasingly on biological drugs and targeted therapies matched to the tumor's genetic profile. These drugs are very expensive and are sometimes not in the basket at the moment treatment is needed. Here the out-of-basket rider, alongside cover for advanced medical technologies, can make a substantial difference.

Note that cover for a personalized drug is usually conditional on it meeting the policy's definitions (type of drug, approval in a recognized country, suitable medical indication). It is therefore worth checking in advance — not only at the moment of truth — what conditions your policy sets.

Diagnostic imaging and lab tests

Diagnosing and monitoring cancer requires repeated imaging and lab tests. Private policies commonly add high coverage for private diagnostic tests — CT, PET-CT, and MRI — as well as for specialized lab tests used to detect and characterize malignancies.

• The main advantage is often speed and availability: shortening the wait for a critical test can directly affect how quickly treatment decisions are made.
• Some policies require a referral or prior approval, and some require the test to be done within a specific network — details worth confirming before committing.
• Genomic tumor-profiling tests, which guide the choice of targeted therapy, sometimes fall under the tests clause or under a separate clause.

Second opinions, and critical-illness insurance as a separate product

Many policies include the right to a second medical opinion from a specialist, sometimes abroad — an important tool before major treatment decisions. It is important to distinguish medical-expense cover from critical-illness insurance, which is a different product: it pays a one-time lump sum on diagnosis of a covered illness, regardless of actual expenses, and is meant for financial flexibility rather than reimbursing treatment costs.

The two products can complement each other, but they are bought and claimed separately. If you are not sure exactly what you hold, this is a good moment to get your policy documents and read them before you need them.

How Ravit can help

Ravit helps you understand what your policy actually says. You send your policy documents on WhatsApp, ask in free language — for example "Is an out-of-basket oncology drug covered for me?" or "What is my cover for a PET-CT?" — and get an answer grounded in your specific policy, with a pointer to the relevant clause so you can verify it yourself. When the information is partial or ambiguous, Ravit says so honestly and flags low confidence instead of guessing.

The information in this article is general only and does not constitute medical, insurance, legal, or pension advice, and is not a substitute for reading your policy terms or consulting a licensed professional. Coverage, amounts, and conditions vary between policies and change over time — always verify against your own specific policy and an authorized professional.